4 results
The primary objective of the trial is to demonstrate non-inferiority of treatment with TMC278 when administered as 75 mg q.d. compared to the control group (EFV) in regard to the proportion of virologic responders (plasma viral load < 50 HIV-…
Primary objective:To determine the response to a 144-hour (6 day) continuous intravenous infusion of SAGE-547 compared to placebo administered to support the weaning of all third-line agents in subjects with SRSE, and for the response to endure at…
The aim of the current study is to assess the feasibility, safety and efficacy of the Steam ablation System for eradication of small BE areas
Evaluate the formation of adhesions after third-generation endometrial ablation, with and without the intrauterine adhesion barrier